47
Participants
Start Date
January 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
April 30, 2011
dasatinib
Tablets, Oral, 100 mg, once daily, 6 months
Hospital For Special Surgery, New York
University Of Pittsburgh, Pittsburgh
Georgetown University Hospital, Washington D.C.
Medical University Of South Carolina, Charleston
University Of Michigan, Ann Arbor
West Michigan Rheumatology, Grand Rapids
Northwestern University Feinberg School Of Medicine, Chicago
Mayo Clinic Arizona, Scottsdale
Ucla Division Of Rheumatology, Los Angeles
University Of Connecticut Health Center, Farmington
Boston University School Of Medicine, Boston
Umdnj Clinical Research Center, New Brunswick
Rhode Island Hospital, Providence
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY